fulvestrant has been researched along with Pituitary Neoplasms in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (37.50) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 9 (37.50) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z; Liu, Z; Shao, Z; Song, C; Wang, X; Xiao, Z; Yang, X; Zhang, K | 1 |
| Chumpen, S; De Paul, A; Gutierrez, S; Nicola, JP; Perez, P; Petiti, JP; Picech, F; Sosa, LDV; Torres, AI; Valdez-Taubas, J | 1 |
| Bartsch, JW; Carl, B; Hannen, R; Nimsky, C; Steffani, M; Voellger, B; Wang, J | 1 |
| Bai, J; Gui, S; Zhang, Y | 1 |
| Cacciamali, A; Cocchi, D; Faggi, L; Giustina, A; Spinello, M; Tulipano, G | 1 |
| Bai, G; Cao, L; Gao, H; Gui, S; Lu, R; Wang, F; Zhang, Y | 1 |
| Cao, L; Gao, H; Gui, S; Li, P; Zhang, Y | 1 |
| Bai, J; Lan, X; Li, C; Li, Z; Liu, Q; Wu, Y; Yu, G; Zhang, Y; Zong, X | 1 |
| Guo, Y; Knosp, E; Liang, Q; Tai, G; Wang, W; Zhao, Y | 1 |
| Cao, L; Gao, H; Gu, Y; Liu, C; Liu, Q; Shan, X; Wang, H; Xue, Y; Zhang, Y | 1 |
| Banerjee, S; Banerjee, SK; Saxena, N; Sengupta, K | 1 |
| Arzt, E; Newton, CJ; Stalla, GK | 1 |
| Buric, R; Newton, CJ; Pagotto, U; Renner, U; Stalla, GK; Trapp, T | 1 |
| Brockmeier, S; Buric, R; Newton, CJ; Pagotto, U; Stalla, GK; Trapp, T | 1 |
| Newton, CJ | 1 |
| Chun, TY; Gorski, J; Gregg, D; Sarkar, DK | 1 |
| Chun, TY; Gray, WG; Stahl, S | 1 |
| Atkin, SL; Burgoyne, CH; Drummond, N; Newton, CJ; Speirs, V; Stalla, GK | 1 |
| Chen, TT; Lin, DH; Sarkar, DK; Ying, C | 1 |
| Heinrich, CA; Lail-Trecker, MR; Peluso, JJ; White, BA | 1 |
| Chun, TY; Gorski, J | 1 |
| Atkin, SL; Eycott, K; Green, V; Newton, CJ | 1 |
| Atkin, SL; Bilko, D; Newton, CJ; Pappa, S | 1 |
| Fernando, M; Heaney, AP; Melmed, S | 1 |
24 other study(ies) available for fulvestrant and Pituitary Neoplasms
| Article | Year |
|---|---|
Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas.
Topics: Adolescent; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cell Line, Tumor; Cyclin D1; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Hypophysectomy; Male; MAP Kinase Signaling System; Middle Aged; Neoplasm Recurrence, Local; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Receptors, Prolactin; Young Adult | 2020 |
The ERα membrane pool modulates the proliferation of pituitary tumours.
Topics: Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cells, Cultured; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Fulvestrant; Gene Expression; Lipoylation; MAP Kinase Signaling System; Pituitary Neoplasms; Rats, Wistar | 2019 |
Effects of anti-estrogens on cell invasion and survival in pituitary adenoma cells: A systematic study.
Topics: Adenoma; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Survival; Estrogen Receptor Antagonists; Fulvestrant; Humans; Neoplasm Invasiveness; Pituitary Neoplasms; Selective Estrogen Receptor Modulators | 2019 |
Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomas.
Topics: Adult; Animals; beta Catenin; Bromocriptine; Cell Line; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Hormone Antagonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Rats; Young Adult | 2013 |
Interplay between the intracellular energy sensor AMP-activated protein kinase (AMPK) and the estrogen receptor activities in regulating rat pituitary tumor cell (GH3) growth in vitro.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Antimetabolites; Cell Line, Tumor; Deoxyglucose; Estradiol; Estrogen Receptor Antagonists; Fulvestrant; Pituitary Neoplasms; Protein Serine-Threonine Kinases; Rats; Receptors, Estrogen | 2014 |
Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.
Topics: Animals; Cell Line, Transformed; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Extracellular Matrix Proteins; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Indoles; Intercellular Signaling Peptides and Proteins; Maleimides; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Inbred F344; Time Factors | 2014 |
The Wnt/β-catenin signaling pathway is involved in the antitumor effect of fulvestrant on rat prolactinoma MMQ cells.
Topics: Animals; Antineoplastic Agents, Hormonal; Azacitidine; beta Catenin; Cell Line, Tumor; Cell Proliferation; Decitabine; Estradiol; Estrogen Receptor alpha; Extracellular Matrix Proteins; Fulvestrant; Intercellular Signaling Peptides and Proteins; Pituitary Neoplasms; Prolactinoma; Rats; Wnt Signaling Pathway | 2014 |
The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas.
Topics: Adult; Animals; Antineoplastic Agents; Bromocriptine; Cell Line, Tumor; Dopamine Agonists; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Male; Middle Aged; Phosphorylation; Pituitary Neoplasms; Prolactinoma; Protein Processing, Post-Translational; Rats; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Young Adult | 2015 |
Differential effects of estrogen and estrogen receptor antagonist, ICI 182 780, on the expression of calbindin-D9k in rat pituitary prolactinoma GH₃ cells.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Estradiol; Estrogen Receptor Antagonists; Fluorescent Antibody Technique; Fulvestrant; Immunoprecipitation; Pituitary Neoplasms; Prolactinoma; Rats; Reverse Transcriptase Polymerase Chain Reaction; S100 Calcium Binding Protein G | 2014 |
ESR1 and its antagonist fulvestrant in pituitary adenomas.
Topics: Adenoma; Adolescent; Adult; Aged; Animals; Antineoplastic Agents; Apoptosis; Butadienes; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cohort Studies; Estradiol; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Female; Fulvestrant; Humans; Male; Middle Aged; Neoplasm Invasiveness; Nitriles; Pituitary Neoplasms; Rats, Inbred F344; Signal Transduction; Young Adult | 2017 |
17alpha-estradiol-induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway.
Topics: Androstadienes; Angiogenesis Inducing Agents; Animals; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Fulvestrant; Gene Expression; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Pituitary Neoplasms; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Puromycin; Rats; Receptors, Estrogen; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Wortmannin | 2003 |
Involvement of the estrogen receptor in the growth response of pituitary tumor cells to interleukin-2.
Topics: Animals; Cell Division; Culture Media; Estradiol; Estrogen Antagonists; Fulvestrant; Genes, Reporter; Interleukin-2; Pituitary Neoplasms; Rats; Receptors, Estrogen; Signal Transduction; Transfection; Tumor Cells, Cultured | 1994 |
The oestrogen receptor modulates growth of pituitary tumour cells in the absence of exogenous oestrogen.
Topics: Animals; Base Sequence; Cell Division; Culture Media, Serum-Free; Estradiol; Fulvestrant; Insulin; Insulin-Like Growth Factor I; Molecular Sequence Data; Neoplasm Proteins; Pituitary Neoplasms; Polyunsaturated Alkamides; Rats; Receptors, Estrogen; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; Transfection; Tumor Cells, Cultured; Vitellogenins | 1994 |
The unliganded estrogen receptor (ER) transduces growth factor signals.
Topics: Base Sequence; Cell Division; Culture Media, Conditioned; Culture Media, Serum-Free; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Insulin; Insulin-Like Growth Factor I; Ligands; Molecular Sequence Data; Oligodeoxyribonucleotides; Pituitary Neoplasms; Polyunsaturated Alkamides; Receptors, Estrogen; Signal Transduction; Tumor Cells, Cultured | 1994 |
Estrogen receptor blockade by the pure antiestrogen, ZM 182780, induces death of pituitary tumour cells.
Topics: Animals; Cell Death; Culture Media; Culture Media, Conditioned; DNA Damage; Dose-Response Relationship, Drug; Estradiol; Estriol; Estrogen Antagonists; Estrone; Fulvestrant; Hydroxytestosterones; Luciferases; Pituitary Neoplasms; Prolactin; Rats; Receptors, Estrogen; Steroids; Time Factors; Tumor Cells, Cultured | 1995 |
Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth.
Topics: Animals; Cell Division; Diethylstilbestrol; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Kinetics; Ovariectomy; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344; Receptors, Estrogen; Tumor Cells, Cultured | 1998 |
Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line.
Topics: Animals; Blotting, Northern; Cell Division; DNA; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Estrogens, Non-Steroidal; Fulvestrant; Inhibitory Concentration 50; Isoflavones; Phytoestrogens; Pituitary Neoplasms; Plant Preparations; Plants; Prolactin; Rats; Rats, Inbred F344; Receptors, Estrogen; RNA, Messenger; Time Factors; Tumor Cells, Cultured | 1998 |
Functional inactivation of the oestrogen receptor by the antioestrogen, ZM 182780, sensitises tumour cells to reactive oxygen species.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Antioxidants; Cell Death; DNA Fragmentation; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Fulvestrant; Hydrogen Peroxide; Membrane Potentials; Mitochondria; Pituitary Neoplasms; Rats; Reactive Oxygen Species; Receptors, Estrogen; Tumor Cells, Cultured | 1999 |
Interaction between estrogen receptor and Pit-1 protein is influenced by estrogen in pituitary cells.
Topics: Animals; Cell Line; Cloning, Molecular; Diethylstilbestrol; DNA-Binding Proteins; Escherichia coli; Estradiol; Estrogen Antagonists; Estrogens; Ethanol; Fulvestrant; Gene Expression Regulation; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Receptors, Estrogen; Recombinant Fusion Proteins; Transcription Factor Pit-1; Transcription Factors; Tumor Cells, Cultured | 1999 |
Negative regulation of N-cadherin-mediated cell-cell adhesion by the estrogen receptor signaling pathway in rat pituitary GH3 cells.
Topics: Animals; Antineoplastic Agents; beta Catenin; Cadherins; Cell Adhesion; Cell Division; Cytoskeletal Proteins; Estradiol; Fluorescent Antibody Technique; Fulvestrant; Microscopy, Confocal; Microscopy, Electron; Pituitary Neoplasms; Rats; Receptors, Estrogen; Signal Transduction; Trans-Activators; Tumor Cells, Cultured | 1999 |
High concentrations of bisphenol A induce cell growth and prolactin secretion in an estrogen-responsive pituitary tumor cell line.
Topics: Animals; Antineoplastic Agents; Benzhydryl Compounds; Cell Division; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Female; Fulvestrant; Neoplasms, Hormone-Dependent; Phenols; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344; Receptors, Estrogen; Secretory Rate; Tumor Cells, Cultured | 2000 |
Response of estrogen receptor containing tumour cells to pure antiestrogens and the calmodulin inhibitor, calmidzolium chloride.
Topics: Breast Neoplasms; Calmodulin; Cell Death; Dose-Response Relationship, Drug; Drug Synergism; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Imidazoles; Neoplasms, Hormone-Dependent; Pituitary Neoplasms; Receptors, Estrogen; Tumor Cells, Cultured | 2000 |
Dexamethasone blocks antioestrogen- and oxidant-induced death of pituitary tumour cells.
Topics: Adenosine Triphosphate; Cell Death; Dexamethasone; Estradiol; Estrogen Receptor Modulators; Estrone; Flow Cytometry; Flutamide; Fulvestrant; Glucocorticoids; Glyceraldehyde-3-Phosphate Dehydrogenases; Gonanes; Humans; Hydrogen Peroxide; Microscopy, Fluorescence; Mifepristone; Pituitary Neoplasms; Reactive Oxygen Species; Receptor Cross-Talk; Receptors, Cell Surface; Transfection; Tumor Cells, Cultured | 2001 |
Functional role of estrogen in pituitary tumor pathogenesis.
Topics: Adenoma; Animals; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Regulation; Humans; Neoplasm Proteins; Pituitary Neoplasms; Rats; Rats, Inbred F344; Rats, Inbred WF; Rats, Long-Evans; Securin | 2002 |